PermeaDerm Study Shows Lower Costs, Comparable Wound Healing vs Allograft
PermeaDerm reduced product cost by 70% and preparation time by 95.7% compared with cadaveric allograft while achieving comparable clinical outcomes in a randomized study.
PermeaDerm reduced product cost by 70% and preparation time by 95.7% compared with cadaveric allograft while achieving comparable clinical outcomes in a randomized study.
Operating with a 16W diode, the platform expands full-body skin revitalization settings across mJOULE and JOULE X systems.